CN107287107A - A kind of circulating tumor cell separation equipment, system and method - Google Patents
A kind of circulating tumor cell separation equipment, system and method Download PDFInfo
- Publication number
- CN107287107A CN107287107A CN201610190332.XA CN201610190332A CN107287107A CN 107287107 A CN107287107 A CN 107287107A CN 201610190332 A CN201610190332 A CN 201610190332A CN 107287107 A CN107287107 A CN 107287107A
- Authority
- CN
- China
- Prior art keywords
- sample
- module
- cell
- circulating tumor
- tumor cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000005443 Circulating Neoplastic Cells Diseases 0.000 title claims abstract description 96
- 238000000926 separation method Methods 0.000 title claims abstract description 37
- 238000000034 method Methods 0.000 title claims abstract description 21
- 210000004027 cell Anatomy 0.000 claims abstract description 49
- 239000006249 magnetic particle Substances 0.000 claims abstract description 18
- 210000004369 blood Anatomy 0.000 claims abstract description 13
- 239000008280 blood Substances 0.000 claims abstract description 13
- 239000006285 cell suspension Substances 0.000 claims abstract description 13
- 238000010790 dilution Methods 0.000 claims abstract description 11
- 239000012895 dilution Substances 0.000 claims abstract description 11
- 210000003743 erythrocyte Anatomy 0.000 claims description 13
- 238000003756 stirring Methods 0.000 claims description 9
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 8
- 238000002347 injection Methods 0.000 claims description 8
- 239000007924 injection Substances 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- 238000005070 sampling Methods 0.000 claims description 7
- 238000005119 centrifugation Methods 0.000 claims description 6
- 230000002572 peristaltic effect Effects 0.000 claims description 6
- 239000002699 waste material Substances 0.000 claims description 6
- 238000012545 processing Methods 0.000 claims description 5
- 239000000243 solution Substances 0.000 claims description 5
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000011248 coating agent Substances 0.000 claims description 3
- 238000000576 coating method Methods 0.000 claims description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 3
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 claims description 3
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 claims description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 3
- 229910052710 silicon Inorganic materials 0.000 claims description 3
- 239000010703 silicon Substances 0.000 claims description 3
- 238000003320 cell separation method Methods 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims description 2
- 238000007710 freezing Methods 0.000 claims description 2
- 230000002209 hydrophobic effect Effects 0.000 claims description 2
- 239000004033 plastic Substances 0.000 claims description 2
- 229920003023 plastic Polymers 0.000 claims description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims description 2
- 229920001440 poly(ε-caprolactone)-block-poly(ethylene glycol) Polymers 0.000 claims description 2
- 239000004926 polymethyl methacrylate Substances 0.000 claims description 2
- 150000005846 sugar alcohols Polymers 0.000 claims description 2
- 239000000463 material Substances 0.000 claims 1
- XEBWQGVWTUSTLN-UHFFFAOYSA-M phenylmercury acetate Chemical compound CC(=O)O[Hg]C1=CC=CC=C1 XEBWQGVWTUSTLN-UHFFFAOYSA-M 0.000 claims 1
- 238000001514 detection method Methods 0.000 abstract description 5
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 238000004140 cleaning Methods 0.000 abstract description 3
- 230000035484 reaction time Effects 0.000 abstract description 2
- 230000001360 synchronised effect Effects 0.000 abstract description 2
- 210000004881 tumor cell Anatomy 0.000 description 13
- 210000005259 peripheral blood Anatomy 0.000 description 8
- 239000011886 peripheral blood Substances 0.000 description 8
- 206010028980 Neoplasm Diseases 0.000 description 7
- 230000001413 cellular effect Effects 0.000 description 7
- 238000004043 dyeing Methods 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 206010006187 Breast cancer Diseases 0.000 description 5
- 208000026310 Breast neoplasm Diseases 0.000 description 5
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 5
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 5
- 239000011324 bead Substances 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 4
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 4
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 201000005202 lung cancer Diseases 0.000 description 4
- 208000020816 lung neoplasm Diseases 0.000 description 4
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 4
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 229940127219 anticoagulant drug Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000007850 fluorescent dye Substances 0.000 description 3
- 238000001215 fluorescent labelling Methods 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 108091023037 Aptamer Proteins 0.000 description 2
- 229920000375 Poly(ethylene glycol)-block-poly(ε−caprolactone) methyl ether Polymers 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 210000003040 circulating cell Anatomy 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 102000029797 Prion Human genes 0.000 description 1
- 108091000054 Prion Proteins 0.000 description 1
- 108091058545 Secretory proteins Proteins 0.000 description 1
- 102000040739 Secretory proteins Human genes 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 125000002015 acyclic group Chemical group 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 210000004493 neutrocyte Anatomy 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
- C12M23/16—Microfluidic devices; Capillary tubes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/20—Material Coatings
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/48—Automatic or computerized control
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
- C12M47/04—Cell isolation or sorting
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Sustainable Development (AREA)
- Analytical Chemistry (AREA)
- Clinical Laboratory Science (AREA)
- Cell Biology (AREA)
- Computer Hardware Design (AREA)
- Dispersion Chemistry (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The invention belongs to biological and medical science, it is related to the equipment, system and method that a kind of high-purity from mixed cell population of the circulating tumor cell by blood sample is separated.The equipment and system of the circulating tumor cell separation, including but not limited to control module, sample introduction module, separation module and collection module.The control module is used for set device operational factor, including dilution volume, reaction time, sample introduction speed, cleaning parameterses etc., the sample introduction module is used for detection sample automatic dilution using multichannel valve module and wriggling pump module and starts the separation of sample multi-channel synchronous, the separation module includes magnet module and separator module, magnet module is used for the blood leucocyte for separating the immune labeled magnetic particle mark of absorption, cell separator module is used for the concentration and separation CTC from many cells colony, and collecting module is used to collect separated circulating tumor cell suspension.The invention provides a kind of circulating tumor cell separation equipment and system, and the method for separating identification circulating tumor cell.
Description
Technical field
The present invention relates to a kind of circulating tumor cell separation equipment, system and method.
Background technology
Circulating tumor cell（CTC）It is to be split away off from primary cancer cell tissue into human peripheral blood and tissue
Circulating cancer cells, CTC has extremely important meaning for the early diagnosis of cancer, the assessment of therapeutic effect.Due to CTC quantity
It is extremely rare, it may only contain several to dozens of circulating tumor cells per 10mL blood, but be up to about 100,000,000 leucocytes
With 50,000,000,000 red blood cells（ZheXN, CherML, BonfilRD, Am.J.Cancer Res.2011,1,740-751）, in quantity
Circulating tumor cell can not directly be detected under the interference of huge background cells, this detection includes gene mutation, surface mark
Will thing, cytoactive, secretory protein spectrum and mechanical property etc., swell so CTC is separated from peripheral blood as circulation
Necessary step before oncocyte detection.Between in the past few decades, a variety of skills to capture cancer cell are developed
Art, such as fluorescent immune method, magnetic immuno method.However, the expensive equipment needed for these technologies, operating method is complicated, promote difficult
Degree is big.Therefore, exploitation high flux, quick separating, CTC capture instruments simple to operate are significantly.
At present from human peripheral separate CTC method can be divided mainly into two classes, this two classes method also represent simultaneously from
Complex biological, which imitates, separates the main policies of rare cell in product.One class method is based on CTC and other cell physics in blood
The difference of property, such as density, size, the difference of soft or hard degree realize CTC and the separation of other cells, such as pass through 8 microns
The screen pack in aperture carries out filtering and removes the leucocyte for being less than 8 micron-scales, but such method has higher heteroproteose cell background,
The tumour cell obtained simultaneously causes to be difficult to survive and carries out subsequent experimental due to needing to elute again；The another kind of main base of method
The difference of other cell surface markers in CTC and blood, based on the specific antigen on circulating tumor cell surface, by solid
The antibody or accounting aptamers for circulating tumor cell surface specific antigen being scheduled on substrate surface or magnetic-particle are real
The specificity capture of existing circulating tumor cell is simultaneously separated with the realization of the cell of other in blood.CellSearch systems are to circulating tumor
The separation of cell is namely based on this method.Such technological deficiency is that epithelial origin tumour cell can only be captured, with higher
False negative, other separate sources tumour cells of missing inspection, enters the tumour cells such as mesenchymal derivation, source of human stem cell.
In recent years by the way that microflow control technique to be combined with antibody/aptamers capture and develop a series of circulating tumor
Cell chip capture technique, can keep CTC activity, in order to improve the capture rate of its microchannel, current research weight
Point concentrates on microchannel surface in shape, such as micro-pillar array chip（N.Engl. J.Med.2008,359,366-377）、
Surface has periodicity concaveconvex structure " fish bone well " chip (Proc.Natl.Acad.Sci.U.S.A.2010,107,18392-
18397) etc..But, there is following defect in such technology and system：
1）The CTC purity of capture is relatively low, there is non-specific adsorption, false positive easily occurs.
2）The tumour cell of capture is fixed in chip surface, it is impossible to which release carries out follow-up detection.
The content of the invention
It is an object of the present invention to provide a kind of circulating tumor cell (CTC) capture device that can solve the problem that problem above and side
Method.
A kind of circulating tumor cell separation equipment, is made up of sampling device, separator, collection device and control device,
The sampling device is made up of multiple sample introduction needles controlled by peristaltic pump and stirring rod, for will detect sample automatic dilution and open
Dynamic sample multi-channel synchronous separation, the separator is by magnet module（For separating the immune labeled magnetic particle mark of absorption
Blood leucocyte）And separator module（For the concentration and separation CTC from many cells colony）Composition, the separator module is by more
Individual single channel micro-fluidic chip composition, the micro-fluidic chip is spirality channel, and channel width is 100 ~ 1000 microns, height
For 50 ~ 200 microns, length is 10 ~ 100 centimetres, and the micro-fluidic chip is provided with 1 injection port and 2 ~ 3 outlets, sample introduction
The cell sample importing micro-fluidic chip that mouth is used to remove after leucocyte, outlet is used for the circulating tumor after separation is thin
Born of the same parents and cell waste liquid are directed respectively into collection conduit and waste solution channel, and injection port is connected with the sample introduction needle of sampling device, outlet point
Do not connected with circulating tumor cell pipeline and cell waste solution channel；The collection device（For collecting separated circulating tumor
Cell suspension）Connected by circulating tumor cell pipeline with separator；The control device is computer or single-chip microcomputer, is set
There are control flow and control panel, for setting equipment operational factor, including dilution volume, reaction time, sample introduction speed, cleaning ginseng
Number etc..
Specifically, the micro-fluidic chip is by upper strata PDMS or PMMA polymer chip and the slide or silicon chip of lower floor
Carrier carries out sealing-in and formed, or is formed using PC plastic injections.Micro-fluidic chip is on the inside of chip channel by amphipathic polymerization
Thing (such as PEG-PCL, PCL-PEG, PCL-PLA-PEG) is modified by hydrophobic effect coating.
The equipment belongs to automatic sampling, efficiently separates enrichment CTC system, and described equipment and system can disposably be located
Multiple peripheral blood sample separated in synchronization are managed, sample treatment volume can reach 20ml, and cell volume is in 1ml or so, energy after separation
Enough it is directly used in the subsequent experimentals such as cell culture, gene extraction.Solve circulating tumor cell capture non-specific and can not be rich
Collect the technical bottleneck such as circulating tumor cell of capture, this CTC separation equipments and system are more than 90% to CTC enriching and recoverings efficiency, right
Leucocyte removal efficiency is more than more than 99.99%.
The invention further relates to a kind of circulating tumor cell separation method, methods described includes：
（1）Blood sample to be measured is after anti-freezing processing or erythrocyte splitting processing, with anti-CD45 antibody labelings in addition sample cell
Immune magnetic particle preincubate, obtain cell suspension；
（2）Dilution is added in sample cell cell suspension, after stirring is mixed 15 ~ 20 minutes, driving magnet module inhales magnetic particle
Sample tube wall is attached to, the sample liquid in sample cell is extracted and progress in single channel micro-fluidic chip is entered with 0.5 ~ 5 ml/min flow velocitys
Separation；The micro-fluidic chip is spirality channel, and channel width is 100 ~ 1000 microns, is highly 50 ~ 200 microns, length
For 10 ~ 100 centimetres；
（3）Circulating tumor cell cell suspension is obtained in single channel micro-fluidic chip outlet.
Specifically, the step（1）For：After blood sample to be measured is handled through erythrocyte splitting, 1500rpm centrifugation removals are split
Red blood cell is solved, is scattered in again in 50ml sample cells, the interior PBS for containing 0.5%BSA, 2mM EDTA added with 5ml per sample cell,
PH7.5, while often pipe adds the immune magnetic particles of 100 μ l1mg/ml.
The present invention mainly removes leucocyte background in portion perimeter blood by immune magnetic particle, micro-fluidic by non-marked
The noninvasive separation and concentration CTC of chip channel.CTC is realized to leucocyte removal and micro-fluidic chip physical separation by immune magnetic particle
The noninvasive separation of high-purity, completely maintains CTC activity.As shown in Figure 2, circulating tumor cell separator disclosed in this invention
Operation principle is：Dilution is drawn into the sample that magnetic particle reagent is immunized added with clinical sample and anti-CD45 magnetic beads by peristaltic pump
In QC, automatic stirring is mixed, and reacts at room temperature 15min, is started plus magnetic, is adsorbed what is combined by immune magnetic particle under magnetic fields
After leucocyte, absorption 10min, in the case where keeping magnetic fields, liquid in sample cell is imported into cell separator, by separator
In duct centrifugation, purpose circulating tumor cell is separated, into sample cell A, B, remaining acyclic tumour cell then enters
Waste fluid channel.
The present invention have developed can rely on physical separation CTC micro-fluidic chip system by non-antibody, with existing miniflow
Control system is compared, with without antibody labeling, the unique advantage of not injuring tumor cell.The comprehensive nanometer magnetic particle of the present invention is removed
Leucocyte technology and micro-fluidic chip isolation technics, can significantly improve separated CTC cell purities.
The technical scheme that the present invention is provided compared with prior art, has the following advantages that and feature：
1）Non-antibody is relied on, and CTC separation purities are high.Effectively solve prior art and non-specificity is separated to circulating tumor cell.It is logical
Cross immune magnetic particle and remove leucocyte, with reference to micro-fluidic chip physical separation tumour cell.Captured with existing Cell Search and be
System only limitation capture epithelial origin tumour cell is compared, and CTC capture ranges is improved, while greatly improving CTC purity.
2）Noninvasive separation, keeps CTC activity, due to using micro-fluidic physical separation mode, realizes to the efficient richnesses of CTC
Collection, the CTC cell suspensions obtained are not required to be fixed in chip or magnetic pole, need not move through secondary elution, effectively maintain CTC work
Property.Available for the detection of CTC subsequent genes, cell culture, drug sensitive experiment etc..
3）System operatio is simple, high flux sample introduction, and automation Chengdu is high.
4）Cost is lower, and this equipment and system solution cost are lower, with reference to the dyeing of subsequent cell form, it is easier to base
Layer medical system marketing.
Brief description of the drawings
Fig. 1 is circulating tumor cell separation device structure schematic diagram of the present invention.
Fig. 2 is circulating tumor cell piece-rate system fundamental diagram of the present invention.It is peripheral blood sample that A liquid is cleaned in figure
Product dilution, cleaning B liquid is corrective maintenance liquid, predominantly sodium hypochlorite composition.
Fig. 3 is the lung cancer CTC cellular morphology figures isolated；
Fig. 4 is cancer of pancreas CTC fluoroscopic image figures；
Fig. 5 is the breast cancer CTC cellular morphology figures isolated.
Embodiment
With reference to specific embodiment, the present invention is described further, but protection scope of the present invention is not limited in
This：
Embodiment 1：
As shown in figure 1, the circulating tumor cell capture device that the present invention is provided includes control module（1:Control flow, 7：Control
Plate）, sample introduction module（2:Sample introduction needle and stirring rod）, separation module（5:Magnetizer, 3：Separator）, collection module（4:Sample is received
Collect frame）.
The separator is made up of multiple single channel micro-fluidic chips, and the micro-fluidic chip is by upper strata PDMS polymer
Chip and the reversible sealing-in of the silicon chip carrier of lower floor are formed, and are spirality channel, channel width is 600 microns, highly micro- for 100
Rice, length is 50 centimetres, and micro-fluidic chip inwall coating amphipathic nature polyalcohol PEG-PCL, the micro-fluidic chip is provided with 1
Injection port（Connected with sample introduction needle）With 2 outlets（Circulating tumor cell outlet and waste liquid outlet）, remove after leucocyte
Cell sample micro-fluidic chip is entered by injection port, the circulating cells suspension after separation is by circulating cells outlet through collecting pipe
Road is delivered to the sample export outflow of collecting frame, is collected by sample collection tube.
In order to illustrate the system and existing other circulating tumor cell piece-rate system performance differences.Respectively by 1x103It is personal
The tumour cell MGC803 of the eGFP expression of work culture is respectively scattered in Whole Blood of Healthy sample 2ml, is disclosed respectively by this patent
NextctcCTC capture instrument and Cell search capture systems carry out CTC separation.Fluorescence microscope is counted after separation
MGC803 quantity in cell suspension, calculates capture rate.Nextctc capture rates are 81%, more than Cell Search capture rates
60%.
In order to illustrate this equipment and the system separation circulating tumor cell course of work, present invention selection lung cancer patient diagnosed 13
People, after ethics approval and patient's informed consent, everyone extracts peripheral blood 3ml, inserts in EDTA anticoagulant tubes.
Circulating tumor cell separation process：
1）, preparation of samples：After being handled through erythrocyte splitting, after 1500rpm centrifugations, splitting erythrocyte is removed, is scattered in and adds again
There is 5ml to contain in 0.5%BSA, 2mM EDTA PBS（pH7.5）50ml centrifuge tubes（Sample cell）In, while adding 100 μ
The immune magnetic particle of l1mg/ml anti-CD45 antibody labelings（Wherein CD45 antibody is purchased from Abcam companies, and magnetic bead is self-control 1mM carboxylics
Base water-soluble solution）.
2）By on sample cell insertion apparatus Nextctc specimen holders, instrument brings into operation program 1 minute, and control flow prompting is defeated
Enter patient information, set after operational factor, click starts.Instrument injects dilution, and 10 minutes, magnetic are stablized in stirring motor operation
Iron pushes motor operation, magnetic bead is adsorbed onto into sample tube wall, peristaltic pump pumps sample is with 3 ml/min flow velocitys through separator stream
Enter the sample collection tube on sample collection frame.
3）Capture CTC identification.The CTC cell suspensions that sample collection tube is collected, are handled through Gimsa-Wright dyeing,
Microscope is taken pictures, and identifies tumour cell form.Simultaneously using anti-PanCK antibody, anti-CD45 antibody and the DAPI of fluorescence labeling
Dyeing, counts the CTC quantity that CK is positive, CD45 is negative.
Table 1：The CTC quantity statistics tables captured in the clinical peripheral blood from patients with lung cancer sample of 13 separation
| Reference numeral | Clinical sample is numbered | CTC quantity |
| 1 | 1290116367 | 18 |
| 2 | 1290116169 | 55 |
| 3 | 1290113745 | 19 |
| 4 | 1290115989 | 17 |
| 5 | 1290113893 | 8 |
| 6 | 129081107H | 15 |
| 7 | 129062040H | 18 |
| 8 | 129085516H | 3 |
| 9 | 129063465H | 1 |
| 10 | 129085489H | 10 |
| 11 | 129084389H | ＞ 100 |
| 12 | 129084767H | 23 |
| 13 | 129085414H | 21 |
Fig. 3 is the lung cancer CTC cellular morphology figures isolated, and as a result shows that CTC cellular morphologies are complete, nucleus, cell membrane boundary line
It is clear.About 15 microns of cell dia size, hence it is evident that the neutrophil leucocyte small more than girth and leucocyte.Show, the present invention
Disclosed apparatus and method being capable of efficiently concentrating circulating tumor cell.
Embodiment 2:
The people of cancer of pancreas patient diagnosed 5 is selected, after ethics approval and patient's informed consent, everyone extracts the ml of peripheral blood 7.5, puts
Enter in EDTA anticoagulant tubes.
Circulating tumor cell separation process：
1）, preparation of samples：After being handled through erythrocyte splitting, after 1700rpm centrifugations, splitting erythrocyte is removed, is scattered in and adds again
There is 5ml to contain in 0.5%BSA, 2mM EDTA PBS（pH7.5）50ml centrifuge tubes（Sample cell）In, add simultaneously
Magnetic particle is immunized in 50ul1mg/ml.
2）By on sample cell insertion apparatus Nextctc specimen holders, instrument brings into operation program 1 minute, and control flow prompting is defeated
Enter patient information, set after operational factor, click starts.Instrument injects dilution, and 15 minutes, magnetic are stablized in stirring motor operation
Iron pushes motor operation, magnetic bead is adsorbed onto into sample tube wall, peristaltic pump pumps sample is with 2 ml/min flow velocitys through separator stream
Enter the sample collection tube on sample collection frame.
3）Capture CTC identification.The CTC cell suspensions that sample collection tube is collected, are handled through Gimsa-Wright dyeing,
Microscope is taken pictures, and identifies tumour cell form.Simultaneously using anti-PanCK antibody, anti-CD45 antibody and the DAPI of fluorescence labeling
Dyeing, counts the CTC quantity that CK is positive, CD45 is negative.
Fig. 4 is cancer of pancreas CTC fluoroscopic image figures, and it is circulating tumor cell as a result to show the negative cells of CK positives CD45
（CTC ）, the DAPI positives show with intact cell nuclear morphology.Show that present device can efficiently separate cancer of pancreas CTC.
Embodiment 3:
The people of breast cancer patient diagnosed 5 is selected, after ethics approval and patient's informed consent, everyone extracts peripheral blood 5ml, inserts
In EDTA anticoagulant tubes.
Circulating tumor cell separation process：
1）, preparation of samples：After being handled through erythrocyte splitting, after 1800rpm centrifugations, splitting erythrocyte is removed, is scattered in and adds again
There is 5ml to contain in 0.5%BSA, 2mM EDTA PBS（pH7.5）50ml centrifuge tubes（Sample cell）In, while adding 80ul
Magnetic particle is immunized in 1mg/ml.
2）By on sample cell insertion apparatus Nextctc specimen holders, instrument brings into operation program 1 minute, and control flow prompting is defeated
Enter patient information, set after operational factor, click starts.Instrument injects dilution, and 15 minutes, magnetic are stablized in stirring motor operation
Iron pushes motor operation, magnetic bead is adsorbed onto into sample tube wall, peristaltic pump pumps sample is with 2.5 ml/min flow velocitys through separator
The sample collection tube flowed on sample collection frame.
3）Capture CTC identification.The CTC cell suspensions that sample collection tube is collected, are handled through Gimsa-Wright dyeing,
Microscope is taken pictures, and identifies tumour cell form.Simultaneously using anti-PanCK antibody, anti-CD45 antibody and the DAPI of fluorescence labeling
Dyeing, counts the CTC quantity that CK is positive, CD45 is negative.
Fig. 5 is the breast cancer CTC cellular morphology figures isolated, as a result show it is separated go out breast cancer CTC cellular morphologies
Leucocyte is substantially distinguished over, cell size is significantly greater than leucocyte, and CTC has clearly cellular prion protein.The breast cancer is suffered from
Person be in a clinical stage phase, show present device, system and method can effectively realize tumour early stage identification and
CTC is separated.
Claims (5)
1. a kind of circulating tumor cell automates separation equipment, by sampling device, separator, collection device and control device group
Into, it is characterised in that：The sampling device is made up of multiple sample introduction needles controlled by peristaltic pump and stirring rod, the separator
It is made up of magnet module and separator module, the separator module is made up of multiple single channel micro-fluidic chips, the miniflow
Control chip is spirality channel, and channel width is 100 ~ 1000 microns, is highly 50 ~ 200 microns, and length is 10 ~ 100 centimetres,
The micro-fluidic chip is provided with 1 injection port and 2 ~ 3 outlets, and injection port is connected with the sample introduction needle of sampling device, goes out sample
Mouth is connected with circulating tumor cell pipeline and cell waste solution channel respectively；The collection device by circulating tumor cell pipeline with
Separator is connected；The control device is computer or single-chip microcomputer, is provided with control flow and control panel.
2. equipment as claimed in claim 1, it is characterised in that the micro-fluidic chip is by upper strata PDMS, PMMA polymer core
Either silicon chip carrier sealing-in is formed or formed by PC material plastic injections for piece and the slide of lower floor.
3. micro-fluidic chip as claimed in claim 2, it is characterised in that by amphipathic nature polyalcohol (such as PEG- on the inside of chip channel
PCL, PCL-PEG, PCL-PLA-PEG, PMAL etc.) modified by hydrophobic effect coating.
4. a kind of circulating tumor cell separation method, methods described includes：
Blood sample to be measured is added pre- with the immune magnetic particles of anti-CD45 in sample cell after anti-freezing processing or erythrocyte splitting processing
It is incubated, obtains cell suspension；
Dilution is added in sample cell cell suspension, after stirring is mixed 15 ~ 20 minutes, magnetic particle is adsorbed onto by driving magnet module
Sample liquid in sample tube wall, extraction sample cell is entered with 0.5 ~ 5 ml/min flow velocitys to be divided in single channel micro-fluidic chip
From；The micro-fluidic chip is spirality channel, and channel width is 100 ~ 1000 microns, is highly 50 ~ 200 microns, length is
10 ~ 100 centimetres；
Circulating tumor cell cell suspension is obtained in single channel micro-fluidic chip outlet.
5. the method as described in claim 1, it is characterised in that the step（1）For：Blood sample to be measured is through erythrocyte splitting
After processing, 1500rpm centrifugations remove splitting erythrocyte, are scattered in again in 50ml sample cells, interior per sample cell to contain added with 5ml
0.1 ~ 1%BSA, 1 ~ 5 mM EDTA PBS, pH7.5, while often pipe adds the immune magnetic particles of the mg/ml of 100 ~ 500 μ 11.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610190332.XA CN107287107A (en) | 2016-03-30 | 2016-03-30 | A kind of circulating tumor cell separation equipment, system and method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610190332.XA CN107287107A (en) | 2016-03-30 | 2016-03-30 | A kind of circulating tumor cell separation equipment, system and method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107287107A true CN107287107A (en) | 2017-10-24 |
Family
ID=60087759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610190332.XA Pending CN107287107A (en) | 2016-03-30 | 2016-03-30 | A kind of circulating tumor cell separation equipment, system and method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107287107A (en) |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107603848A (en) * | 2017-08-18 | 2018-01-19 | 东华大学 | A kind of preparation method for the micro-fluidic chip for embedding amphion functionalized nano-fiber film |
| CN108226547A (en) * | 2017-12-22 | 2018-06-29 | 东南大学 | Circulating tumor cell detecting instrument including micro-fluidic chip |
| CN108344615A (en) * | 2018-01-24 | 2018-07-31 | 杭州安弼晟生物科技有限公司 | A kind of circulating tumor cell capture systems and control method |
| CN108660060A (en) * | 2018-08-13 | 2018-10-16 | 苏州绘真医学检验有限公司 | It is a kind of enrichment, purification cycle tumour cell micro-fluidic chip |
| CN109486653A (en) * | 2018-11-27 | 2019-03-19 | 上海昆道生物技术有限公司 | Trace cell capture system based on micro-fluidic and immune Magneto separate dual strategy |
| CN110632069A (en) * | 2019-08-20 | 2019-12-31 | 西人马帝言(北京)科技有限公司 | Circulating tumor cell detection method, device, equipment and medium |
| CN111235021A (en) * | 2020-03-06 | 2020-06-05 | 大连海事大学 | Device and method for separating and detecting circulating tumor cells in dual-phase peripheral blood |
| CN112899232A (en) * | 2021-03-03 | 2021-06-04 | 河南省肿瘤医院 | Automatic system for separating circulating tumor cells from blood sample |
| CN113533134A (en) * | 2021-08-04 | 2021-10-22 | 山西农业大学 | Circulating detection system and method for detecting pig red blood cell immunoadhesion function |
| WO2021213257A1 (en) * | 2020-04-21 | 2021-10-28 | 山东第一医科大学(山东省医学科学院) | Detection and identification method for circulating tumor cells (ctcs) |
| CN114250140A (en) * | 2020-09-22 | 2022-03-29 | 深圳市瑞格生物科技有限公司 | Circulating tumor cell separating and capturing device and method thereof |
| CN116358980A (en) * | 2023-06-01 | 2023-06-30 | 翔鹏佑康(北京)科技有限公司 | Tumor cell short-term test identification device |
| CN118436418A (en) * | 2024-05-15 | 2024-08-06 | 北京大学 | Circulating tumor cell in-vivo cleaning system |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103589629A (en) * | 2013-11-15 | 2014-02-19 | 上海康微健康科技有限公司 | Separation system for CTCs (circulating tumor cells) |
| CN103998932A (en) * | 2011-06-29 | 2014-08-20 | 中央研究院 | Capture, purification and release of biological substances using surface coatings |
| CN105067808A (en) * | 2015-07-30 | 2015-11-18 | 南京医科大学 | High-purity circulation tumor cell enriching method and kit |
-
2016
- 2016-03-30 CN CN201610190332.XA patent/CN107287107A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103998932A (en) * | 2011-06-29 | 2014-08-20 | 中央研究院 | Capture, purification and release of biological substances using surface coatings |
| CN103589629A (en) * | 2013-11-15 | 2014-02-19 | 上海康微健康科技有限公司 | Separation system for CTCs (circulating tumor cells) |
| CN105067808A (en) * | 2015-07-30 | 2015-11-18 | 南京医科大学 | High-purity circulation tumor cell enriching method and kit |
Non-Patent Citations (3)
| Title |
|---|
| SUN ET AL.: "Double spiral microchannel for label-free tumor cell separation and enrichment", 《LAB CHIP》 * |
| 吴海霞等: "两亲性共聚物刷修饰的抗蛋白吸附表面的制备及研究", 《2015 年全国高分子学术论文报告会》 * |
| 杜晶辉等: "微流控芯片分选富集循环肿瘤细胞的研究进展", 《色谱》 * |
Cited By (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107603848B (en) * | 2017-08-18 | 2020-11-13 | 东华大学 | Preparation method of microfluidic chip embedded with zwitterion functionalized nanofiber membrane |
| CN107603848A (en) * | 2017-08-18 | 2018-01-19 | 东华大学 | A kind of preparation method for the micro-fluidic chip for embedding amphion functionalized nano-fiber film |
| CN108226547A (en) * | 2017-12-22 | 2018-06-29 | 东南大学 | Circulating tumor cell detecting instrument including micro-fluidic chip |
| CN108344615A (en) * | 2018-01-24 | 2018-07-31 | 杭州安弼晟生物科技有限公司 | A kind of circulating tumor cell capture systems and control method |
| CN108344615B (en) * | 2018-01-24 | 2020-10-23 | 杭州安弼晟生物科技有限公司 | Circulating tumor cell capturing system and control method |
| CN108660060A (en) * | 2018-08-13 | 2018-10-16 | 苏州绘真医学检验有限公司 | It is a kind of enrichment, purification cycle tumour cell micro-fluidic chip |
| CN108660060B (en) * | 2018-08-13 | 2023-12-08 | 苏州绘真医学检验有限公司 | Microfluidic chip for enriching and purifying circulating tumor cells |
| CN109486653B (en) * | 2018-11-27 | 2022-03-22 | 上海昆道生物技术有限公司 | A Trace Cell Capture System Based on Dual Strategies of Microfluidics and Immunomagnetic Separation |
| CN109486653A (en) * | 2018-11-27 | 2019-03-19 | 上海昆道生物技术有限公司 | Trace cell capture system based on micro-fluidic and immune Magneto separate dual strategy |
| CN110632069A (en) * | 2019-08-20 | 2019-12-31 | 西人马帝言(北京)科技有限公司 | Circulating tumor cell detection method, device, equipment and medium |
| CN111235021B (en) * | 2020-03-06 | 2022-09-27 | 大连海事大学 | Double-liquid-phase separation and detection device and method for circulating tumor cells in peripheral blood |
| CN111235021A (en) * | 2020-03-06 | 2020-06-05 | 大连海事大学 | Device and method for separating and detecting circulating tumor cells in dual-phase peripheral blood |
| WO2021213257A1 (en) * | 2020-04-21 | 2021-10-28 | 山东第一医科大学(山东省医学科学院) | Detection and identification method for circulating tumor cells (ctcs) |
| CN114250140A (en) * | 2020-09-22 | 2022-03-29 | 深圳市瑞格生物科技有限公司 | Circulating tumor cell separating and capturing device and method thereof |
| CN112899232B (en) * | 2021-03-03 | 2022-02-01 | 河南省肿瘤医院 | Automatic system for separating circulating tumor cells from blood sample |
| CN112899232A (en) * | 2021-03-03 | 2021-06-04 | 河南省肿瘤医院 | Automatic system for separating circulating tumor cells from blood sample |
| CN113533134A (en) * | 2021-08-04 | 2021-10-22 | 山西农业大学 | Circulating detection system and method for detecting pig red blood cell immunoadhesion function |
| CN116358980A (en) * | 2023-06-01 | 2023-06-30 | 翔鹏佑康(北京)科技有限公司 | Tumor cell short-term test identification device |
| CN116358980B (en) * | 2023-06-01 | 2023-09-29 | 翔鹏佑康(北京)科技有限公司 | Tumor cell short-term test identification device |
| CN118436418A (en) * | 2024-05-15 | 2024-08-06 | 北京大学 | Circulating tumor cell in-vivo cleaning system |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yu et al. | ExoSD chips for high-purity immunomagnetic separation and high-sensitivity detection of gastric cancer cell-derived exosomes | |
| CN106076441B (en) | A kind of micro fluidic device and method based on size detection circulating tumor cell | |
| CN103756967B (en) | Application of the monoclonal antibody coupling immunomagnetic beads of anti-HLA-G in tumour cell sorting | |
| CN104178454B (en) | A kind of enrichment of circulating tumor cell, analysis method | |
| CN107402295B (en) | Microfluidic chip for automatic separation and purification of circulating tumor cells and separation and purification method thereof | |
| CN108795869A (en) | A kind of circulating tumor cell positive enrichment method | |
| US20110195413A1 (en) | Integrated Method for Enriching and Detecting Rare Cells from Biological Body Fluid Sample | |
| CN110079457A (en) | Micro-fluidic chip and excretion body extracting method | |
| CN103869060A (en) | Circulating tumor stem cell detection kit based on magnetic beads and microfluidic chip | |
| CN109486653A (en) | Trace cell capture system based on micro-fluidic and immune Magneto separate dual strategy | |
| CN103940997B (en) | A kind of breast carcinoma circulating tumor cell detecting system and test kit | |
| CN109856388A (en) | The catching method and capture kit of circulating tumor cell | |
| CN103031276A (en) | Method for obtaining circulating tumor single-cell | |
| CN107402303A (en) | Circulating tumor cell separation and concentration micro-fluidic chip and its enrichment method | |
| CN107075556A (en) | Methods and systems for cell separation using magnetic and size-based separation | |
| CN107449713A (en) | Method dependent on the circulating tumor cell sorting and enrichment of mixed antibody | |
| Chen et al. | Development of new techniques and clinical applications of liquid biopsy in lung cancer management | |
| CN109777775A (en) | A kind of circulating tumor cell separation method | |
| Ni et al. | Inertia-magnetic microfluidics for rapid and high-purity separation of malignant tumor cells | |
| CN105087493A (en) | Joint application of three types of monoclonal antibody-coupled immunomagnetic beads to sorting tumor cells | |
| CN107400623A (en) | Circulating tumor cell automatic capture micro-fluidic chip and its automatic capture method | |
| CN106244553A (en) | The separation of circulating tumor cell and detection method | |
| CN206787889U (en) | A kind of device for separating and being enriched with body fluid components | |
| CN106701684A (en) | High-efficiency circulating tumor cell enrichment method | |
| CN109161530B (en) | Separation method of circulating tumor cells based on phenylboronic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171024 |
|
| RJ01 | Rejection of invention patent application after publication |